The largest database of trusted experimental protocols

Abi mycoseq mycoplasma detection assay

Manufactured by Thermo Fisher Scientific

The ABI MycoSEQ mycoplasma detection assay is a real-time PCR-based assay designed to detect the presence of mycoplasma contamination in cell culture samples. The assay utilizes primers and probes targeting conserved regions of the mycoplasma 16S rRNA gene, allowing for the sensitive and specific detection of a wide range of mycoplasma species.

Automatically generated - may contain errors

3 protocols using abi mycoseq mycoplasma detection assay

1

Characterization of GM12878 Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
GM12878 cells were obtained from Coriel Institute for Medical Research. Species of origin of the cell line was confirmed by PCR targeting the glucose-6-phosphate dehydrogenase gene. Donor subject has a single bp (G-to-A) transition at nucleotide 681 in exon 5 of the CYP2C19 gene (CYP2C19*2) which creates an aberrant splice site. Donor origin of the cell line was confirmed using PCR against the point mutation. The cell line was tested for mycoplasma contamination using ABI MycoSEQ mycoplasma detection assay (Applied Biosystems). Cells were propagated in RPMI 1640 (11875-093, Gibco) plus 15% fetal bovine serum (26140-079, Gibco), 100 U penicillin (15140-122, Gibco), and 100mg/ml streptomycin (15140-122, Gibco) at 37°C in a humidified incubator containing 5% CO2. Cells were sub-cultured every two days to maintain them in exponential growth phase.
+ Open protocol
+ Expand
2

Characterization of GM12878 Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
GM12878 cells were obtained from Coriel Institute for Medical Research. Species of origin of the cell line was confirmed by PCR targeting the glucose-6-phosphate dehydrogenase gene. Donor subject has a single bp (G-to-A) transition at nucleotide 681 in exon 5 of the CYP2C19 gene (CYP2C19*2) which creates an aberrant splice site. Donor origin of the cell line was confirmed using PCR against the point mutation. The cell line was tested for mycoplasma contamination using ABI MycoSEQ mycoplasma detection assay (Applied Biosystems). Cells were propagated in RPMI 1640 (11875-093, Gibco) plus 15% fetal bovine serum (26140-079, Gibco), 100 U penicillin (15140-122, Gibco), and 100mg/ml streptomycin (15140-122, Gibco) at 37°C in a humidified incubator containing 5% CO2. Cells were sub-cultured every two days to maintain them in exponential growth phase.
+ Open protocol
+ Expand
3

Enhancer Activity Assay in Jurkat Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Jurkat cells were purchased from ATCC (TIB-152). The cell line was tested for mycoplasma contamination using ABI MycoSEQ mycoplasma detection assay (Applied Biosystems). Enhancer sequences containing predicted risk eSNPs were cloned using In-Fusion HD Cloning Kit (Clontech, Cat # 639648) into a luciferase reporter construct pGL3-HS in which expression of the luciferase gene is driven by a minimal heat-shock promoter. Sanger sequencing was used to determine the alleles of the risk eSNPs. Two control regions of ~2 kb without either H3K4me1 or H3K27ac signals were cloned into the same plasmid as negative controls. Reporter constructs were transfected into Jurkat cells using TransIT-Jurkat Reagent (Mirus Bio, MIR 2120). As an internal control, a plasmid containing Renilla luciferase (pRL-TK from Promega) was co-transfected at a molar ratio of 1:10 for Renilla vs firefly luciferases. Cells were collected 48 h post transfection and luciferase reporter levels were measured and compared to Renilla luciferase reporter activity using the Dual-Luciferase Reporter Assay kit (Promega, cat # E1910). Primer sequences for cloning enhancers and mutagenesis are listed in Supplementary Tables 7 and 8.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!